Aveanna Healthcare (NASDAQ:AVAH) Insider Edwin Reisz Sells 17,613 Shares

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) insider Edwin Reisz sold 17,613 shares of the stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $138,262.05. Following the completion of the transaction, the insider owned 1,321,114 shares of the company’s stock, valued at $10,370,744.90. This trade represents a 1.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Aveanna Healthcare Price Performance

NASDAQ AVAH opened at $8.08 on Friday. The stock’s 50-day moving average price is $8.92 and its two-hundred day moving average price is $7.49. The company has a current ratio of 1.23, a quick ratio of 1.23 and a debt-to-equity ratio of 140.39. The company has a market cap of $1.69 billion, a PE ratio of 22.44 and a beta of 2.06. Aveanna Healthcare Holdings Inc. has a 1 year low of $3.67 and a 1 year high of $10.32.

Aveanna Healthcare (NASDAQ:AVAH) last announced its earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The company had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%. On average, analysts predict that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of AVAH. Summit Partners L P bought a new stake in Aveanna Healthcare during the second quarter valued at about $50,477,000. Assenagon Asset Management S.A. acquired a new position in shares of Aveanna Healthcare during the 3rd quarter worth about $7,356,000. Strs Ohio bought a new stake in Aveanna Healthcare during the 1st quarter valued at approximately $218,000. Diversified Trust Co acquired a new stake in Aveanna Healthcare in the 2nd quarter valued at approximately $57,000. Finally, Squarepoint Ops LLC increased its position in Aveanna Healthcare by 207.0% in the 2nd quarter. Squarepoint Ops LLC now owns 479,977 shares of the company’s stock worth $2,510,000 after buying an additional 323,656 shares during the period. Institutional investors own 87.96% of the company’s stock.

Wall Street Analyst Weigh In

AVAH has been the topic of several recent analyst reports. Truist Financial boosted their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the company a “hold” rating in a research note on Friday, November 7th. JPMorgan Chase & Co. raised Aveanna Healthcare from an “underweight” rating to a “neutral” rating and upped their price target for the company from $6.00 to $10.00 in a research report on Thursday, September 18th. Jefferies Financial Group raised their price objective on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. Zacks Research cut Aveanna Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, October 20th. Finally, William Blair began coverage on shares of Aveanna Healthcare in a research note on Monday, December 8th. They issued an “outperform” rating on the stock. Five analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $10.69.

Aveanna Healthcare News Summary

Here are the key news stories impacting Aveanna Healthcare this week:

• Negative Sentiment: CEO Jeff Shaner sold multiple blocks (roughly 83,000+ shares across Dec. 30–Jan. 2 in the filings), at prices around $8.18–$8.36, reducing his stake by about 1–1.2% in individual trades while retaining a multi‑million‑share holding — investors may view repeated CEO sales as a negative signal. SEC filing — Jeff Shaner
• Negative Sentiment: CFO Matthew Buckhalter executed several sales (totaling ~70,000+ shares across Dec. 30–Jan. 2) at roughly $7.85–$8.36, each reducing his position by ~3.5–4%. Repeated CFO sales can raise governance/comfort concerns for short‑term holders. SEC filing — Matthew Buckhalter
• Negative Sentiment: CAO Deborah Stewart sold multiple blocks (~34,000+ shares across Dec. 30–Jan. 2) at similar price levels, trimming her stake by ~4% in reported trades while keeping a substantial holding — another senior exec sale that may pressure sentiment. SEC filing — Deborah Stewart
• Negative Sentiment: Insider Edwin C. Reisz sold multiple tranches (~51,000+ shares across Dec. 30–Jan. 2) at $7.85–$8.36, reducing his position by ~1.2% in several filings. Multiple insider sellers across ranks amplify negative interpretation. SEC filing — Edwin C. Reisz
• Negative Sentiment: Insider Patrick A. Cunningham reported several sales (~36,000+ shares across Dec. 30–Jan. 2) at similar price points, lowering his stake by ~3.6–4.1% in the disclosed trades. Collective insider selling increases perceived supply risk. SEC filing — Patrick A. Cunningham

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.